Inactive Instrument

Highlights Horizon Pharma Inc Nasdaq

Equities

US44047T1097

End-of-day quote Nasdaq Other stock markets
- ^USD	-

Jan. 16	Health Canada Approves Horizon Therapeutics plc 's UPLIZNA® (inebilizumab for injection) for the Treatment of Neuromyelitis Optica Spectrum Disorders	CI
2023	Global markets live: Boeing, Amgen, Microsoft, Volkswagen, Tesla...

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Health Canada Approves Horizon Therapeutics plc 's UPLIZNA® (inebilizumab for injection) for the Treatment of Neuromyelitis Optica Spectrum Disorders	Jan. 16	CI
Global markets live: Boeing, Amgen, Microsoft, Volkswagen, Tesla...	23-10-09
Amgen completes $27.8 bln Horizon deal	23-10-06	RE
Amgen Completes Acquisition of Horizon Therapeutics	23-10-06	MT
Amgen completes acquisition of Horizon Therapeutics	23-10-06	RE
Horizon Therapeutics Public Limited Company's Equity Buyback announced on September 9, 2022, has expired.	23-10-05	CI
Amgen Inc. completed the acquisition of Horizon Therapeutics Public Limited Company.	23-10-05	CI
Amgen Wins Irish Court Approval to Acquire Horizon Therapeutics	23-10-05	MT
Horizon Therapeutics Public Limited Company Announces New Analysis of Adhering to Uninterrupted Full Course of Treatment with Tepezza to Support Thyroid Eye Disease Patient Outcomes	23-09-29	CI
EMEA Morning Briefing : Shares Seen Lower at Start of the Week	23-09-25	DJ
Horizon Therapeutics, Q32 Bio Say First Patient Dosed in Phase 2 Trial of Bempikibart in Severe Alopecia Areata	23-09-13	MT
Q32 Bio and Horizon Therapeutics plc Announce Dosing of First Patient in Phase 2 Trial of Bempikibart for Severe Alopecia Areata	23-09-13	CI
FTC settlement could shelter Amgen from US price cuts, taxes	23-09-05	RE
News Highlights : Top Company News of the Day	23-09-03	DJ
Amgen Settles FTC, State Challenges to Horizon Therapeutics Deal	23-09-01	MT
Top Stories at Midday: Wall Street Cheers Jobs Data; Dell Crushes Estimates; Broadcom Pales Next to Nvidia; FTC Gives OK to Amgen, Horizon Merger	23-09-01	MT
Amgen Reaches Settlement With FTC to Move Ahead With Horizon Acquisition	23-09-01	MT
Amgen Reportedly Settles With FTC on Horizon Therapeutics Merger, Bloomberg Says	23-09-01	MT
U.S. FTC allows Amgen to move forward with $27.8 bln Horizon deal - CNBC	23-09-01	RE
Top Stories at Midday: 3M to Settle Ear-Plug Lawsuit; Boston Scientific's A-Fib Therapy Meets Endpoint; Merger Monday	23-08-28	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Horizon Pharma Inc Nasdaq

Equities

US44047T1097

Highlights

Filters